Northern Trust Corp Has $863.45 Million Holdings in Colgate-Palmolive (NYSE:CL)

Northern Trust Corp lifted its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 11.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,497,819 shares of the company's stock after purchasing an additional 993,328 shares during the period. Northern Trust Corp owned 1.16% of Colgate-Palmolive worth $863,447,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of CL. Gerber Kawasaki Wealth & Investment Management grew its position in shares of Colgate-Palmolive by 19.1% during the 4th quarter. Gerber Kawasaki Wealth & Investment Management now owns 3,588 shares of the company's stock worth $326,000 after buying an additional 575 shares during the period. Boothbay Fund Management LLC raised its position in shares of Colgate-Palmolive by 26.3% during the 4th quarter. Boothbay Fund Management LLC now owns 4,609 shares of the company's stock valued at $419,000 after acquiring an additional 959 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter worth $9,011,000. Coldstream Capital Management Inc. grew its stake in shares of Colgate-Palmolive by 15.8% during the fourth quarter. Coldstream Capital Management Inc. now owns 13,553 shares of the company's stock worth $1,232,000 after purchasing an additional 1,854 shares during the period. Finally, Two Sigma Securities LLC increased its holdings in Colgate-Palmolive by 22.2% in the fourth quarter. Two Sigma Securities LLC now owns 2,444 shares of the company's stock valued at $222,000 after purchasing an additional 444 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Analysts Set New Price Targets

CL has been the subject of a number of recent analyst reports. Citigroup upped their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research report on Monday, April 28th. Piper Sandler decreased their price objective on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. Royal Bank of Canada restated a "sector perform" rating and set a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Stifel Nicolaus dropped their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a report on Monday, February 3rd. Finally, JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $102.39.

Colgate-Palmolive Price Performance

NYSE CL traded down $0.27 during trading on Friday, hitting $90.42. 4,715,657 shares of the company's stock were exchanged, compared to its average volume of 4,641,548. The company has a market cap of $73.28 billion, a PE ratio of 25.69, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock's 50 day moving average price is $92.26 and its two-hundred day moving average price is $91.78.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The firm's revenue was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.86 EPS. Research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be paid a $0.52 dividend. The ex-dividend date is Thursday, April 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.30%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio is currently 58.76%.

Colgate-Palmolive announced that its board has authorized a share buyback plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its stock is undervalued.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.